Regulation of Staphylococcus aureus Virulence and Application of Nanotherapeutics to Eradicate S. aureus Infection
Pharmaceutics · 17.01.2023 · 15 (2) · 310
DOI: 10.3390/pharmaceutics15020310 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 17.01.2023. Verfasst von Kannappan Arunachalam und 3 weiteren Autor:innen. Beteiligte Einrichtung: MOST-USDA Joint Research Center for Food Safety, Department of Food Science and Technology, School of Agriculture and Biology, and State Key Laborato…. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
Staphylococcus aureus is a versatile pathogen known to cause hospital- and community-acquired, foodborne, and zoonotic infections. The clinical infections by S. aureus cause an increase in morbidity and mortality rates and treatment costs, aggravated by the emergence of drug-resistant strains. As a multi-faceted pathogen, it is imperative to consolidate the knowledge on its pathogenesis, including the mechanisms of virulence regulation, development of antimicrobial resistance, and biofilm formation, to make it amenable to different treatment strategies. Nanomaterials provide a suitable platform to address this challenge, with the potential to control intracellular parasitism and multidrug resistance where conventional therapies show limited efficacy. In a nutshell, the first part of this review focuses on the impact of S. aureus on human health and the role of virulence factors and biofilms during pathogenesis. The second part discusses the large diversity of nanoparticles and their applications in controlling S. aureus infections, including combination with antibiotics and phytochemicals and the incorporation of antimicrobial coatings for biomaterials. Finally, the limitations and prospects using nanomaterials are highlighted, aiming to foster the development of novel nanotechnology-driven therapies against multidrug-resistant S. aureus.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MOST-USDA Joint Research Center for Food Safety, Department of Food Science and Technology, School of Agriculture and Biology, and State Key Laboratory of Microbial Metabolism, Shanghai Jiao Tong University, Minhang, Sh…
- Department of Microbiology, M.R. Government Arts College, Mannargudi, Coimbatore 614001, Tamil Nadu, India.
- School of Technology and Management, Polytechnic Institute of Leiria, 2411-901 Leiria, Portugal.
- Applied Molecular Biosciences Unit, NOVA School of Science and Technology, NOVA University of Lisbon, Caparica, 2829-516 Almada, Portugal.
ORCID-Profile: Kannappan Arunachalam, Poonguzhali Pandurangan, Chunlei Shi, Ricardo Lagoa
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- Fundação para a Ciência e Tecnologia
- Science and Technology Commission of Shanghai Municipality of China
- Natural Science Foundation of China
- FCT-Foundation for Science and Technology
Zitieren
APA
Arunachalam, K., Pandurangan, P., Shi, C., & Lagoa, R. (2023). Regulation of Staphylococcus aureus Virulence and Application of Nanotherapeutics to Eradicate S. aureus Infection. Pharmaceutics, 15(2), 310. https://doi.org/10.3390/pharmaceutics15020310
Vancouver
Arunachalam K, Pandurangan P, Shi C, Lagoa R. Regulation of Staphylococcus aureus Virulence and Application of Nanotherapeutics to Eradicate S. aureus Infection. Pharmaceutics. 2023;15(2):310. doi:10.3390/pharmaceutics15020310
BibTeX
@article{Arunachalam2023,
author = {Arunachalam, Kannappan and Pandurangan, Poonguzhali and Shi, Chunlei and Lagoa, Ricardo},
title = {Regulation of Staphylococcus aureus Virulence and Application of Nanotherapeutics to Eradicate S. aureus Infection},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {2},
pages = {310},
doi = {10.3390/pharmaceutics15020310}
}
EUVIMED